C0450000

カルバマゼピン

European Pharmacopoeia (EP) Reference Standard

• 別名: 5H-ジベンズ[b,f]アゼピン-5-カルボキサミド
• 実験式（ヒル表記法）: C₁₅H₁₂N₂O
• CAS番号: 298-46-4
• 分子量: 236.27
• MDL番号: MFCD00005073
• UNSPSCコード: 41116107
• PubChem Substance ID: 329774792
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: carbamazepine
• メーカー／製品名: EDQM
• mp: 191-192 °C (lit.)
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• 保管温度: 2-8°C
• SMILES記法: NC(=O)N1c2ccccc2C=Cc3ccccc13
• InChI: 1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)
• InChI Key: FFGPTBGBLSHEPO-UHFFFAOYSA-N
• 遺伝子情報: human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Carbamazepine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

生物化学的／生理学的作用

抗痙攣薬； GABA _A受容体ベンゾジアゼピン調節部位の配位子。ナトリウムチャンネル阻害剤。

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS08,GHS07
• シグナルワード: Danger
• 危険有害性情報: H302,H317,H334,H336,H360FD
• 注意書き: P202 - P261 - P280 - P301 + P312 - P302 + P352 - P308 + P313
• 危険有害性の分類: Acute Tox. 4 Oral - Repr. 1A - Resp. Sens. 1 - Skin Sens. 1A - STOT SE 3
• ターゲットの組織: Central nervous system
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 2
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable